Coral Laboratories Company Description
Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally.
The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, oral antiseptic, and calcium preparations; mouthwashes; nutritional, protein, and iron supplements; kits; appetizers; and other products.
It also provides sterile products, such as small volume liquid, cephalosporin, betalactam, and lyophilized injectables; eye, ear, and nose drops; nasal sprays and metered dose inhalers; and large volume parenteral.
In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products.
Further, it offers pharmaceutical formulations, including tablets, capsules, ointments, syrups, and injectables.
Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.
| Country | India |
| Founded | 1994 |
| Industry | Pharmaceutical Preparations |
| Employees | 197 |
| CEO | Girish Dhameja |
Contact Details
Address: #3B, Patanwala Industrial Estate Mumbai, Gujarat 400086 India | |
| Phone | 91 22 2500 5245 |
| Website | corallab.com |
Stock Details
| Ticker Symbol | 524506 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Girish Dhameja | Chief Executive Officer |
| Sushma Kadkade | Chief Financial Officer |